| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 24.585 | 38.339 | 38.188 | 43.759 | 37.795 | 44.921 | 53.454 | 44.693 | 50.053 |
| Total Income - EUR | 0 | 24.585 | 38.339 | 38.188 | 43.759 | 37.795 | 44.921 | 53.454 | 44.693 | 50.053 |
| Total Expenses - EUR | 252 | 9.917 | 7.547 | 9.306 | 9.808 | 9.069 | 10.535 | 11.324 | 13.865 | 15.954 |
| Gross Profit/Loss - EUR | -252 | 14.668 | 30.792 | 28.882 | 33.951 | 28.726 | 34.386 | 42.131 | 30.828 | 34.100 |
| Net Profit/Loss - EUR | -252 | 14.176 | 30.408 | 28.500 | 33.513 | 28.367 | 33.968 | 41.691 | 30.390 | 32.628 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Migid Gyn-Ob Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 441 | 108 | 0 | 0 | 0 |
| Current Assets | 56 | 14.845 | 31.641 | 29.827 | 34.763 | 28.637 | 34.580 | 42.512 | 31.393 | 33.973 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 2.787 | 0 | 22.237 | 28.794 | 23.451 | 17.691 |
| Cash | 56 | 14.845 | 31.641 | 29.827 | 31.975 | 28.637 | 12.343 | 13.718 | 7.942 | 16.282 |
| Shareholders Funds | -207 | 13.972 | 30.462 | 28.748 | 33.572 | 28.431 | 34.034 | 41.764 | 30.443 | 32.677 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 262 | 873 | 1.179 | 1.079 | 1.191 | 646 | 653 | 748 | 951 | 1.296 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Migid Gyn-Ob Srl